Four-Tier Pathologic Tumor Regression Grading System Predicts the Clinical Outcome in Patients Who Undergo Surgical Resection for Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy.
Soomin AhnJong-Chan LeeYong-Tae KimYoung Hoon KimYoo-Seok YoonHo-Seong HanHaeryoung KimJin-Hyeok HwangPublished in: Gut and liver (2021)
The four-tier CAP pathologic tumor regression grading system predicted the clinical outcome in LAPC patients who underwent resection after neoadjuvant chemotherapy. Therefore, a more comprehensive pathologic evaluation is warranted in these patients.